# Hypo-FLAME (NCT02853110)

> Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02853110
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: UMC Utrecht
- Conditions: Prostate Cancer Adenocarcinoma
- Interventions: Hypo-FLAME study
- Enrollment: 100
- Primary outcome: Acute toxicity

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 14
- Podcasts: 3
- Bluesky threads: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=hypo-flame-nct02853110

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02853110", "email": "<work email>"}; the inbox owner confirms by the emailed link.